Caffeine and Cannabis Both Alter Brain Chemistry in Young Rats, but in Different Ways

Researchers divided 72 juvenile Wistar rats (approximately 40 days old) into six groups. Controls received nothing; other groups received high-dose caffeine (100 mg/kg), low-dose caffeine (50 mg/kg), high-dose cannabis (500 mg/kg), low-dose cannabis (200 mg/kg), or a combination of low-dose cannabis plus low-dose caffeine. All substances were given orally for 21 days. Brain tissue was then analyzed for neurotransmitter levels (GABA, glutamate, dopamine) and metabolic enzymes (cytochrome C oxidase, G-6-PDH).

Adolescence is a critical period for brain development. Understanding how commonly consumed psychoactive substances affect neurotransmitter systems during this window could inform public health approaches to youth substance use. The finding that combining caffeine and cannabis amplified certain metabolic changes raises questions about how these frequently co-used substances interact in developing brains.

Caffeine and cannabis are two of the most widely used psychoactive substances worldwide, and adolescents frequently consume both. Most research examines each substance in isolation, but this study looked at their combined effects on developing brain chemistry. The results suggest that even at lower individual doses, the combination may produce amplified neurochemical changes that neither substance causes alone.

This was an animal study using oral gavage in rats, which does not perfectly replicate human patterns of consumption. The cannabis doses were high by human standards. The study measured tissue levels at a single time point (24 hours after last dose), so the trajectory of changes over time is unknown. Behavioral outcomes were not assessed, so the functional significance of the neurochemical changes remains unclear.